Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EC allocates Ecu 12,300 million to biotechnology:

This article was originally published in Clinica

Executive Summary

The European Commission is allocating Ecu 12,300 million ($15,000 million) to its 1994-98 biotechnology programme. Areas covered, according to details recently published by the Science, Research and Development Directorate, DG XII, include: genome analysis; cell communication in neurosciences; immunology; and biotechnology information infrastructures. An information package gives the timetable for submitting proposals and details the budgets. For further details, including requests for different language versions of the information package, contact: the Biotechnology Unit (SDME 2/84), 200 rue de la Loi, B-1049 Brussels, Belgium. Fax: +32 (2) 295 53 65.

Topics

UsernamePublicRestriction

Register

MT090524

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel